A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL

NCT06559345 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

276

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia, Pediatric

Interventions

RADIATION: TMLI
RADIATION: TBI
DRUG: Cyclophosphamide

Sponsor

The First Affiliated Hospital of Zhengzhou University